Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
| Brand name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Generic name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Active ingredient(s) | AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL |
| Distributed by / for | Macleods Pharma USA, Inc. Plainsboro, NJ 08536 |
| NDC | 33342-192-07 |
| Full product label | Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg 30 Tablets Rx Only NDC 33342-192-07 Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536 Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, India |
| Recalling firm | Cardinal Health Inc. |
| Distribution | FL, GA, SC |
| Quantity | 33 bottles |
| Recall initiated | 2021-03-15 |
| Report date | 2021-06-02 |
| Recall completed | 2024-06-17 |
| Recall number | D-0509-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗